One Important Issue: The FTC’s GoodRx Crackdown Has Affect

Illustrated by Gabriella Turrisi/Axios

Exit content material materials preview

yesterday’s crackdown A federal regulator’s report on GoodRx highlights elevated efforts by the FTC beneath activist chairman Lina Khan to protect clients’ digital effectively being privateness.

Important causes: of Suggested order Advert concentrating on practices, notably amongst direct-to-consumer firms, can have broad implications for the effectively being tech sector, which is sort of ubiquitous.

Catch up shortly: This order is the first of two for the FTC.

context: Startups and big tech companies are gathering large portions of personal details about fertility, practice, effectively being, and prescriptions that aren’t explicitly protected like totally different info coated by HIPAA.

Zoom in: Notably, the FTC grievance alleges that GoodRx shared personally identifiable details about clients’ prescription drugs and effectively being conditions with Google and Fb.

• The grievance moreover alleges that GoodRx centered clients of telemedicine service HeyDoctor who searched on-line for STDs and displayed adverts for STD testing firms.
• The grievance characterizes such practices as deceptive and unauthorized, and could have wide-ranging ramifications in sectors the place such practices are frequent.

Certain, nonetheless: GoodRx agreed Wednesday to settle, nonetheless talked about it disagreed with the corporate’s allegations and admitted no wrongdoing.

Flashback: Whereas the FTC has taken associated movement recently to step up its movement in the direction of effectively being tech companies, GoodRx’s order targets to bar the company from future advert concentrating on, going extra than in earlier cases. is.

• For example, in 2021, the FTC discovered that fertility app developer Flo shared menstrual cycle and being pregnant info with Google and Fb. settlement To amass client consent sooner than sharing such data, we do not expressly prohibit such actions.

Reverse side: In a press launch issued with the courtroom order, FTC Commissioner Christine S. Wilson talked about the settlement falls fast in that it “would not keep senior administration accountable or change the core GoodRx enterprise model.” talked about.

• “I would have supported an even bigger civil penalty,” Wilson wrote, referring to the company’s earlier market valuation of $18 billion, together with: .”